Leon J. Thal, MD

Affiliations: 
Neuroscience University of California, San Diego, La Jolla, CA 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=27
Website:
http://ucsdnews.ucsd.edu/newsrel/health/thal07.asp
Google:
"Leon Thal"
Bio:

http://www.alzforum.org/spotlight/Thaltribute.asp
http://www.nia.nih.gov/NewsAndEvents/20070209Thal.htm
http://healthspan.ucsd.edu/2010/07/Pages/som-thal-award.aspx

Mean distance: 17.84 (cluster 32)
 
Cross-listing: Alzheimer's Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ayton S, Faux NG, Bush AI, et al. (2015) Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nature Communications. 6: 6760
Tariot PN, Schneider LS, Cummings J, et al. (2011) Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. Archives of General Psychiatry. 68: 853-61
Rapp SR, Legault C, Henderson VW, et al. (2010) Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study. Alzheimer Disease and Associated Disorders. 24: 248-55
Apostolova LG, Thompson PM, Green AE, et al. (2010) 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Human Brain Mapping. 31: 786-97
Vellas B, Black R, Thal LJ, et al. (2009) Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Current Alzheimer Research. 6: 144-51
Hamilton JM, Salmon DP, Galasko D, et al. (2008) Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 22: 729-37
Aisen PS, Schneider LS, Sano M, et al. (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama. 300: 1774-83
van Straaten EC, Harvey D, Scheltens P, et al. (2008) Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. Journal of Neurology. 255: 1302-8
Fleisher AS, Raman R, Siemers ER, et al. (2008) Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Archives of Neurology. 65: 1031-8
Fine EM, Delis DC, Wetter SR, et al. (2008) Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 366-74
See more...